α-mapi

SP-Chymostatin B is a potent inhibitor of many proteases, including chymotrypsin, papain, chymotrypsin-like serine proteinases, chymases, and lysosomal cysteine proteinases. It weakly inhibits human leucocyte elastase. It is effective at a final concentra

MAPI 是一种多肽不可逆 3C 半胱氨酸蛋白酶 (SV3CP) 抑制剂。它通过将其 C 端迈克尔受体延伸物结合到 SV3CP Cys 139 的活性位点硫醇，来抑制该酶的功能。MAPI 有潜力用于诺如病毒感染的研究。

Adezmapimod (SB 203580) 是一种 p38 MAPK 抑制剂 (IC50=0.3-0.5 μM)，具有选择性和 ATP 竞争性。Adezmapimod 具有自噬和线粒体自噬的激活活性。Adezmapimod 显示出比 PKB、LCK 和 GSK-3β 高 100 倍以上的选择性。

Doramapimod (BIRB 796) 是一种具有口服活性的p38 MAPK 抑制剂，Kd 值为0.1nM。它也抑制B-Raf 和 Abl，IC50分别为 83 nM 和 14.6 μM。

Talmapimod (SCIO-469) 是 选择性的，具有口服活性的，ATP 竞争性的 p38α抑制剂，对 p38α和 p38β的 IC50 值分别是 9 nM 和90 nM。Talmapimod 在 20 个其他激酶 (包括其他 MAPKs) 上显示出至少 2000 倍的选择性。

Emprumapimod (PF-07265803) 是一种具有口服活性和特异性的丝裂原活化蛋白激酶 p38α MAPK 抑制剂，抑制 LPS 诱导产生的 IL-6 ，可用于研究 LMNA 基因引起的扩张型心肌病。

Losmapimod (GSK-AHAB) 是一种可口服的特异性 p38 MAPK 抑制剂，抑制 p38α 和 p38β 的 pKi 值分别为 8.1 和 7.6。

Neflamapimod (VX-745) 是一种可穿过血脑屏障的，高选择性的p38α抑制剂，对 p38α 的IC50值为 10 nM，p38β 的IC50值为 220 nM。它对 p38β 的特异性高 22 倍，具有抗炎活性。

Dilmapimod (SB-681323) 是一种 p38 MAPK 的强效抑制剂，可抑制慢性阻塞性肺疾病的炎症。

Talmapimod hydrochloride is a selective and ATP-competitive p38α inhibitor (IC50: 9 nM). It also shows about 10-fold selectivity over p38β, and at least 2000-fold selectivity over a panel of 20 other kinases, including other MAPKs.

Balamapimod is a reversible inhibitor of Ras Raf MEK. It also has a potential anti-tumor activity.

Timapiprant sodium inhibits mast cell activation of Th2 lymphocytes and eosinophils. Timapiprant sodium is a potent and selective D prostanoid receptor 2 antagonist. Timapiprant sodium potently displaces [3H] PGD2 from human recombinant DP2 (Ki=13 nM), ra

Timapiprant (OC000459) 是一种有效的选择性 D 前列腺素受体 2(DP2) 拮抗剂，IC50为 13 nM。它抑制肥大细胞激活 Th2 淋巴细胞和嗜酸性粒细胞，有效地置换来自人重组 DP2、大鼠重组 DP2 和人天然 DP2 的 [3H] PGD2。

Bentamapimod (AS 602801) 是一种ATP 竞争性的JNK 抑制剂，对JNK1、JNK2和JNK3的IC50分别为 80、90 和 230 nM。

Relmapirazin may be used as a diagnostic agent.

Semapimod hydrochloride dihydrate is a biochemical.

Semapimod mesylate is a biochemical.

Telmapitant is an antagonist of the neurokinin NK1 receptor.

Semapimod tetrahydrochloride (CPSI-2364 tetrahydrochloride) 是一种合成鸟腙丝裂原活化蛋白激酶阻滞剂,也是促炎细胞因子生成抑制剂，干扰巨噬细胞和小胶质细胞功能。Semapimod tetrahydrochloride 可抑制 TLR4 信号传导，抑制 TNF-α、IL-1β 和 IL-6，可用于研究克罗恩病和其他炎症。

Rehmapicroside是一种天然产物，属于玄参科地黄属，其产品编号为 T3S0462，CAS号为 104056-82-8。Rehmapicroside可用作对照参考。

Dilmapimod tosylate is a potent p38 mitogen-activated protein kinase (MAPK) inhibitor. It was investigated for its anti-inflammatory effect in non-head injury trauma patients at risk for developing acute respiratory distress syndrome. IL-1β was identified as a gene regulated by dilmapimod that could influence c-reactive protein levels. Dilmapimod had been in phase III clinical trials by GlaxoSmithKline for the treatment of rheumatoid arthritis, neuropathic pain, coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD).

Pamapimod (R1503) 是一种新型的选择性 p38 丝裂原活化蛋白激酶抑制剂，对于p38α和p38β的IC50分别为 14 nM 和 480 nM，Ki 分别为 1.3 nM 和 120 nM，对 p38δ 或 p38γ 亚型没有活性，可研究类风湿关节炎和其他自身免疫性疾病。

Doramapimod HCl is the salt form of Doramapimod, a member of the N-pyrazole-N'-naphthly urea class of p38MAPK inhibitors, which binds to the kinase with both slow association and dissociation rates. BIRB -796 has entered clinical trials for the treatment of autoimmune diseases.

R995045 is a novel delta opioid receptor agonist chemotype.